Deloitte and BMI SYSTEM partner to deliver complete compliance management solution for the Asia Pacific market
Singapore, 18 August 2015 – Deloitte and BMI SYSTEM announced today a strategic alliance that delivers a complete set of compliance, transparency and risk management solutions that aims to help businesses prepare, respond and recover more efficiently and effectively within the pharmaceutical regulation framework.
With pharmaceutical compliance and regulation becoming more and more stringent, evident by the fines the industry has been subject to recently, the strain on companies within this sector to comply and become transparent is ever increasing.
The Deloitte and BMI SYSTEM alliance represents a significant opportunity to help clients in Asia address these compliance and transparency requirements. It will leverage the strength of BMI SYSTEM’s global compliance and transparency NAYA software solutions in conjunction with the breadth and depth of Deloitte’s Life Sciences and Healthcare services designed to improve businesses capabilities in the areas of governance, risk, compliance and regulation.
Non-compliance is becoming visible and can lead to a decrease in a company’s brand image and hence a loss in revenues. “As regulation evolves, the agility and flexibility delivered by our solutions will be key to adapting quickly to market and compliance changes” said Brigitte Dillen, CEO for BMI SYSTEM. “Our combined capabilities enable companies to better prepare and implement the appropriate solutions.”
According to BMI SYSTEM’s Regulatory Affairs Expert, Laurent Clerc: “Right from the beginning, we have endeavored to provide our customers with the most secure, flexible and functionally rich software to meet the stringent regulations and requirements of the life sciences industry. We are more than delighted to combine our global and cross-border in-depth life sciences expertise with Deloitte’s experience and know-how for the mutual benefit of our customers.”
“Together with BMI SYSTEM, we offer a powerful and integrated business and technology solution enabling companies to adequately prepare for and manage the entire life cycle of compliance, transparency and risk management,” said Mohit Grover, Deloitte’s Life Sciences & Health Care Industry Leader in Southeast Asia.
“Organisations today need to rapidly execute strict compliance, transparency and risk management solutions, and we are making it possible for them to enhance business performance while meeting tomorrow’s challenges head-on by providing them with solutions that can help them regain full business strength and improve their capacity to withstand future crises.”